Loading...
Market
First Biomolecule Type Predicted by AlphaFold 3 and Confirmed by 2024
5
Resolution / Starting Odds
Proteins • 25%
DNA • 25%
RNA • 25%
Ligands • 25%
Scientific journals, Google or Isomorphic Labs announcements
Story
Google Launches AlphaFold 3, Expanding AI's Role in Drug Discovery
May 12, 2024, 04:10 PM
Google, in collaboration with Isomorphic Labs, has launched AlphaFold 3, an advanced AI model developed by Google DeepMind. This new version represents a significant step forward from its predecessor, AlphaFold 2, by expanding its capabilities to predict not only the 3D structures of proteins but also the interactions and structures of all biomolecules including DNA, RNA, and ligands. AlphaFold 3 is expected to revolutionize the field of drug discovery by providing detailed predictions of biomolecular structures, thereby enhancing the understanding of cellular mechanics and disease.
View original story
Similar markets
Proteins • 25%
DNA • 25%
RNA • 25%
Ligands • 25%
Drug discovery • 25%
Genetic research • 25%
Cancer research • 25%
Antibody development • 25%
North America • 25%
Europe • 25%
Asia • 25%
Rest of the World • 25%
Genetic diseases • 33%
Agricultural biology • 33%
Environmental science • 33%
Bioinformatics • 33%
Agricultural Genetics • 33%
Environmental Science • 34%
Pharmaceuticals • 20%
Biotechnology • 20%
Cosmetics • 20%
Food and Beverage • 20%
Agriculture • 20%
Widely Adopted • 33%
Moderately Adopted • 34%
Rarely Adopted • 33%